Comparison of the CHADS2, CHA2DS2 -VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: The AMADEUS trial

Overview of attention for article published in Thrombosis and Haemostasis, December 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 25,673 followers.

HAS-BLED scoring system can be used to predict bleeding risk in anticoagulated patients with atrial fibrillation: http://t.co/Uo84Ev9EWI

HAS-BLED scoring system can be used to predict bleeding risk in anticoagulated patients with atrial fibrillation: http://t.co/Uo84Ev9EWI

HAS-BLED scoring system can be used to predict bleeding risk in anticoagulated patients with atrial fibrillation: http://t.co/Uo84Ev9EWI

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.